Call for Study Participants: Using the LyfeMD application to support the management of IBS
Written by: CDHF
Updated: April 20th, 2023
Do you have irritable bowel syndrome (IBS)? Do you have a mobile phone? Are you interested in learning more about individualized lifestyle therapies to manage your IBS?
Alberta’s Center of Excellence for Nutrition in Digestive Diseases (Ascend) is looking for participants to take part in a study to evaluate the effectiveness of their LyfeMD app.
Irritable bowel syndrome (IBS) is the most common functional gastrointestinal (GI) disorder worldwide and affects 12% of the Canadian population.1
Alberta’s Center of Excellence for Nutrition in Digestive Diseases (Ascend) is dedicated to generating novel discoveries regarding the link between diet, nutrition, and brain-gut interactions in patients with digestive diseases.
One of Ascend’s primary initiatives is the development of a digital health platform for patients living with irritable bowel syndrome (IBS). Dr. Raman and her team have developed an app called LyfeMD. LyfeMD is one app with multiple features – ranging from a customized diet using anti-inflammatory principles, exercise plans to mindfulness and stress reduction programs identified from recent research led by Dr. Raman’s team. The app provides personalized and interactive support and uses behaviour science to help patients change their habits and improve their gut health.
The LyfeMD app developed by Ascend could be a valuable tool for individuals with irritable bowel syndrome (IBS) to manage their symptoms and improve their overall health. Conducting a study to evaluate the effectiveness of the app is an important step in understanding its impact on the patients with IBS. The study aims to evaluate the impact of the LyfeMD app on IBS symptoms, mental, and physical health of participants with IBS. By participating in the study, individuals can contribute to the research on the link between diet, nutrition, and brain-gut interactions in patients with IBS and potentially benefit from the holistic and evidence- based lifestyle therapies offered through the app.
For this study, we are looking for people with IBS, who have a mobile phone, and are interested in virtually delivered individualized lifestyle therapies.
If you are interested in participating in the study, please reach out to the research team led by Dr Raman by emailing to ascend@ucalgary.ca to learn more about the study and how to get involved.
Reference
1. IBS Global Impact Report, 2018.
